Display options
Cite
Reusser NM, Downing C, Guidry J, et al. HPV Carcinomas in Immunocompromised Patients. J Clin Med. 2015;4(2):260-81doi: 10.3390/jcm4020260.
Reusser, N. M., Downing, C., Guidry, J., & Tyring, S. K. (2015). HPV Carcinomas in Immunocompromised Patients. Journal of clinical medicine, 4(2), 260-81. https://doi.org/10.3390/jcm4020260
Reusser, Nicole M, et al. "HPV Carcinomas in Immunocompromised Patients." Journal of clinical medicine vol. 4,2 (2015): 260-81. doi: https://doi.org/10.3390/jcm4020260
Reusser NM, Downing C, Guidry J, Tyring SK. HPV Carcinomas in Immunocompromised Patients. J Clin Med. 2015 Jan 29;4(2):260-81. doi: 10.3390/jcm4020260. PMID: 26239127; PMCID: PMC4470124.
Copy Download .nbib Format: NLM
Share it on

J Clin Med. 2015 Jan 29;4(2):260-81. doi: 10.3390/jcm4020260.

HPV Carcinomas in Immunocompromised Patients.

Journal of clinical medicine

Nicole M Reusser, Christopher Downing, Jacqueline Guidry, Stephen K Tyring

Affiliations

  1. Medical School, the University of Texas Health Science Center at Houston, 6431 Fannin, Houston, TX 77030, USA. [email protected].
  2. Center for Clinical Studies, 1401 Binz, Suite 200, Houston, TX 77004, USA. [email protected].
  3. Center for Clinical Studies, 1401 Binz, Suite 200, Houston, TX 77004, USA. [email protected].
  4. Medical School, the University of Texas Health Science Center at Houston, 1401 Binz, Suite 200, Houston, TX 77004, USA. [email protected].

PMID: 26239127 PMCID: PMC4470124 DOI: 10.3390/jcm4020260

Abstract

Human papillomavirus (HPV) infection is the most common sexually transmitted disease worldwide and can result in pre-malignancies or overt malignancies of the skin and mucosal surfaces. HPV-related illnesses are an important personal and public health problem causing physical, mental, sexual and financial detriments. Moreover, this set of malignancies severely affects the immunosuppressed population, particularly HIV-positive patients and organ-transplant recipients. There is growing incidence of HPV-associated anogenital malignancies as well as a decrease in the average age of affected patients, likely related to the rising number of high-risk individuals. Squamous cell carcinoma is the most common type of HPV-related malignancy. Current treatment options for HPV infection and subsequent disease manifestations include imiquimod, retinoids, intralesional bleomycin, and cidofovir; however, primary prevention with HPV vaccination remains the most effective strategy. This review will discuss anogenital lesions in immunocompromised patients, cutaneous warts at nongenital sites, the association of HPV with skin cancer in immunocompromised patients, warts and carcinomas in organ-transplant patients, HIV-positive patients with HPV infections, and the management of cutaneous disease in the immunocompromised patient.

Keywords: carcinogenesis; human Immunodeficiency virus (HIV); human papillomavirus (HPV); immunosuppression; skin cancer; vaccine

References

  1. PLoS One. 2009;4(3):e5018 - PubMed
  2. Transpl Int. 2003 Mar;16(3):146-53 - PubMed
  3. Arch Gynecol Obstet. 2012 Jan;285(1):183-93 - PubMed
  4. Virol J. 2012 Jan 17;9:21 - PubMed
  5. Br J Prev Soc Med. 1976 Jun;30(2):107-14 - PubMed
  6. Clin Infect Dis. 2001 Sep 1;33(5):597-602 - PubMed
  7. JAMA. 2011 Nov 2;306(17):1891-901 - PubMed
  8. Melanoma Res. 2009 Oct;19(5):275-82 - PubMed
  9. Arch Gynecol Obstet. 2003 Feb;267(4):263-5 - PubMed
  10. J Invest Dermatol. 2008 Sep;128(9):2310-5 - PubMed
  11. Open AIDS J. 2013 Dec 30;7:58-66 - PubMed
  12. Case Rep Oncol. 2012 May;5(2):434-8 - PubMed
  13. Clin Infect Dis. 2002 Oct 15;35(Suppl 2):S210-24 - PubMed
  14. Australas J Dermatol. 2004 May;45(2):123-4 - PubMed
  15. Br J Dermatol. 1994 Feb;130(2):221-5 - PubMed
  16. Br J Cancer. 2003 Oct 6;89(7):1221-7 - PubMed
  17. AIDS. 2009 Jun 1;23(9):1135-42 - PubMed
  18. J Clin Virol. 2005 Mar;32 Suppl 1:S82-90 - PubMed
  19. J Drugs Dermatol. 2008 May;7(5):483-5 - PubMed
  20. Obstet Gynecol. 2006 May;107(5):1023-8 - PubMed
  21. Curr Opin HIV AIDS. 2009 Jan;4(1):68-73 - PubMed
  22. Cancer Treat Rev. 2014 Mar;40(2):205-14 - PubMed
  23. J Infect Dis. 2010 Mar;201(5):681-90 - PubMed
  24. Vaccine. 2006 Mar 30;24 Suppl 1:S1-15 - PubMed
  25. J Dermatol Case Rep. 2008 Dec 27;2(4):60-2 - PubMed
  26. N Engl J Med. 2006 Feb 16;354(7):709-18 - PubMed
  27. Arch Dermatol. 2005 Aug;141(8):985-93 - PubMed
  28. Andrologia. 1999;31 Suppl 1:17-20 - PubMed
  29. J Am Acad Dermatol. 2011 Aug;65(2):263-79; quiz 280 - PubMed
  30. Front Oncol. 2012 Apr 11;2:36 - PubMed
  31. J Gen Virol. 2011 Dec;92(Pt 12):2784-91 - PubMed
  32. Cancer. 1994 Sep 15;74(6):1762-7 - PubMed
  33. Clin Exp Dermatol. 2003 Nov;28 Suppl 1:7-9 - PubMed
  34. J Infect Dis. 1998 Feb;177(2):361-7 - PubMed
  35. Microbiol Mol Biol Rev. 2009 Jun;73(2):348-70 - PubMed
  36. Gynecol Oncol. 1996 Jun;61(3):384-6 - PubMed
  37. Clin Exp Dermatol. 2008 Jan;33(1):74-6 - PubMed
  38. Curr Treat Options Oncol. 2012 Sep;13(3):354-76 - PubMed
  39. Clin Cancer Res. 2001 Sep;7(9):2826-31 - PubMed
  40. Br J Dermatol. 2010 Jan;162(1):6-11 - PubMed
  41. Transpl Int. 2007 Mar;20(3):238-46 - PubMed
  42. Am J Pathol. 2008 May;172(5):1391-402 - PubMed
  43. J Med Virol. 2014 Mar;86(3):419-25 - PubMed
  44. Adv Dent Res. 2006 Apr 01;19(1):99-105 - PubMed
  45. Virology. 2013 Nov;446(1-2):378-88 - PubMed
  46. Dis Colon Rectum. 2009 Feb;52(2):239-47 - PubMed
  47. J Infect. 2013 Mar;66(3):207-17 - PubMed
  48. PLoS Pathog. 2012;8(7):e1002807 - PubMed
  49. Am J Transplant. 2009 Nov;9 Suppl 3:S1-155 - PubMed
  50. Med Wieku Rozwoj. 2003 Oct-Dec;7(4 Pt 1):487-93 - PubMed
  51. Biomed Pharmacother. 2012 Sep;66(6):409-13 - PubMed
  52. Dis Colon Rectum. 1980 Nov-Dec;23(8):550-1 - PubMed
  53. Nat Med. 2004 Sep;10(9):909-15 - PubMed
  54. J Drugs Dermatol. 2009 May;8(5):467-74 - PubMed
  55. J Dermatol Surg Oncol. 1985 Oct;11(10):972-3 - PubMed
  56. Curr Opin Oncol. 2013 Sep;25(5):503-10 - PubMed
  57. Eur J Cancer Prev. 2008 Nov;17(6):545-54 - PubMed
  58. AIDS Patient Care STDS. 1998 Apr;12(4):251-4 - PubMed
  59. Biochem Biophys Res Commun. 2011 May 13;408(3):363-8 - PubMed
  60. Infect Dis Clin North Am. 2013 Dec;27(4):765-78 - PubMed
  61. Int J Cancer. 2012 Aug 15;131(4):949-55 - PubMed
  62. Virology. 2010 Aug 1;403(2):128-36 - PubMed
  63. Liver Transpl. 2013 Nov;19(11):1252-61 - PubMed
  64. J Natl Cancer Inst. 2000 Sep 20;92(18):1500-10 - PubMed
  65. Clin Infect Dis. 2002 Mar 1;34(5):641-8 - PubMed
  66. PLoS Pathog. 2010 Apr 08;6(4):e1000852 - PubMed
  67. Clin Dermatol. 2013 Jul-Aug;31(4):362-73 - PubMed
  68. Am J Surg Pathol. 2014 Jul;38(7):973-81 - PubMed
  69. Science. 2006 Sep 29;313(5795):1960-4 - PubMed
  70. J Eur Acad Dermatol Venereol. 2000 Jul;14(4):321-2 - PubMed
  71. J Clin Oncol. 2010 Sep 20;28(27):4142-8 - PubMed
  72. N Engl J Med. 2008 Apr 3;358(14 ):1465-73 - PubMed
  73. Am J Transplant. 2011 Jul;11(7):1498-508 - PubMed
  74. Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1053-9 - PubMed
  75. J Clin Pathol. 1994 Sep;47(9):823-6 - PubMed
  76. Lancet. 2007 Jul 7;370(9581):59-67 - PubMed
  77. Arch Dermatol. 1998 Jan;134(1):25-30 - PubMed
  78. Clin Cancer Res. 2001 Oct;7(10 ):3031-3 - PubMed
  79. Transplantation. 1990 Mar;49(3):506-9 - PubMed
  80. Transplantation. 2010 Nov 15;90(9):986-92 - PubMed
  81. Acta Cytol. 2000 May-Jun;44(3):305-9 - PubMed
  82. Int J Gynecol Cancer. 2009 Oct;19(7):1166-76 - PubMed
  83. J Exp Clin Cancer Res. 2011 Nov 14;30:108 - PubMed
  84. Int J Dermatol. 2014 Apr;53(4):416-24 - PubMed
  85. J Urol. 1995 Jun;153(6):1940-3 - PubMed
  86. Obstet Gynecol. 2012 Nov;120(5):1222-38 - PubMed
  87. Nat Rev Immunol. 2006 Jun;6(6):447-56 - PubMed
  88. AIDS. 1999 Oct 1;13(14):1933-42 - PubMed
  89. J Am Acad Dermatol. 2004 Jun;50(6):980-1 - PubMed
  90. Cutis. 1997 Mar;59(3):119-22 - PubMed
  91. J Natl Cancer Inst. 1993 Jan 6;85(1):19-24 - PubMed
  92. Obstet Gynecol. 1997 May;89(5 Pt 1):690-4 - PubMed
  93. Science. 1999 Oct 15;286(5439):525-8 - PubMed
  94. Transplantation. 2002 Feb 27;73(4):661-2 - PubMed
  95. Antimicrob Agents Chemother. 1998 Apr;42(4):789-94 - PubMed
  96. FASEB J. 2007 Sep;21(11):2765-75 - PubMed
  97. Cell Biosci. 2014 Mar 04;4(1):11 - PubMed
  98. Sex Transm Dis. 2001 Jun;28(6):343-6 - PubMed
  99. J Natl Cancer Inst Monogr. 2003;(31):52-6 - PubMed
  100. Br J Dermatol. 1981 Jul;105(1):71-6 - PubMed
  101. Br J Dermatol. 2007 Dec;157 Suppl 2:25-31 - PubMed
  102. J Am Acad Dermatol. 2012 Jun;66(6):883.e1-17; quiz 899-900 - PubMed
  103. J Gastrointest Surg. 2007 Mar;11(3):272-9 - PubMed
  104. J Am Acad Dermatol. 2006 Nov;55(5):901-3 - PubMed
  105. J Oral Pathol Med. 2013 Jul;42(6):443-9 - PubMed
  106. J Allergy Clin Immunol. 2012 Nov;130(5):1030-48 - PubMed
  107. Thorax. 1992 Mar;47(3):195-6 - PubMed
  108. Vaccine. 2012 Nov 20;30 Suppl 5:F168-74 - PubMed
  109. Cancer. 1986 Aug 1;58(3):611-6 - PubMed
  110. Cancer. 2004 Jul 15;101(2):281-8 - PubMed
  111. Am J Physiol Gastrointest Liver Physiol. 2006 Mar;290(3):G496-504 - PubMed
  112. J Med Virol. 2001 Jun;64(2):195-8 - PubMed
  113. Eur Surg Res. 2006;38(4):418-22 - PubMed
  114. PLoS One. 2010 Apr 08;5(4):e10094 - PubMed
  115. AIDS. 2006 Nov 28;20(18):2337-44 - PubMed
  116. AIDS. 2004 May 21;18(8):1221-3 - PubMed
  117. Foot (Edinb). 2014 Jun;24(2):94-8 - PubMed
  118. Clin Diagn Lab Immunol. 2001 Mar;8(2):209-20 - PubMed
  119. J Am Acad Dermatol. 2002 Apr;46(4):545-8 - PubMed
  120. Br J Dermatol. 2007 Dec;157 Suppl 2:52-5 - PubMed
  121. Lab Invest. 1999 Dec;79(12):1489-99 - PubMed
  122. Dermatol Surg. 2008 Oct;34(10):1299-313 - PubMed
  123. J Infect Dis. 2010 Jun 1;201(11):1677-85 - PubMed
  124. Int J STD AIDS. 2004 Jun;15(6):357-64 - PubMed
  125. Int J STD AIDS. 2008 Jul;19(7):445-9 - PubMed
  126. J Biomed Opt. 2012 Aug;17(8):085002-1 - PubMed

Publication Types